Breaking News Instant updates and real-time market news.

ROKU

Roku

$46.51

0.05 (0.11%)

06:18
08/06/18
08/06
06:18
08/06/18
06:18

Roku price target raised to $43 from $30 at Loop Capital

Loop Capital analyst Alan Gould raised his price target on Roku to $43 ahead of its Q2 results, saying the company has had two consecutive earnings surprises and its trends have remained strong, expecting a 44% revenue growth on 40% rise in active accounts. The analyst notes that Roku has continued to gain market share in connected TV, but also points to "large" amount of insider selling and heightened competition, keeping his Hold rating on the shares.

  • 08

    Aug

ROKU Roku
$46.51

0.05 (0.11%)

07/03/18
07/03/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Albemarle (ALB) upgraded to Buy from Neutral at Goldman Sachs with analyst Robert Koort saying the selloff in companies tied to lithium is overdone. 2. Veon (VEON) upgraded to Overweight from Neutral at JPMorgan with analyst Alexei Gogolev stating that the company shed its Italian business at a "very attractive price". 3. Roku (ROKU) upgraded to Outperform from Perform at Oppenheimer with analyst Jason Helfstein saying the "rapid adoption" of The Roku Channel gives him incremental confidence in the channel's ability to garner viewership on other platforms. 4. Amedisys (AMED) upgraded to Buy from Neutral at BofA/Merrill with analyst Joanna Gajuk stating that last night's CMS proposal increased reimbursement visibility for the home health industry calling for a +2.1% rate update in 2019, the best update since 2007 following nine consecutive years of cuts. 5. NetEase (NTES) upgraded to Overweight from Underweight at JPMorgan with analyst Alex Yao saying he expects NetEase to end a six-quarter "earnings downgrade cycle" with its "lackluster" earnings growth starting to recover in Q2 and peaking in Q1 of 2019. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/17/18
KEYB
07/17/18
NO CHANGE
Target $54
KEYB
Overweight
Roku price target raised to $54 from $44 at KeyBanc
KeyBanc analyst Evan Wingren raised his price target for Roku to $54 from $44 and continues to recommend buying shares on increased confidence in the short- and long-term potential for Roku. The analyst says checks from Key First Look Data of about 6,000 Roku customers in June suggest further acceleration in customer growth, with search volume backing it up. Wingren believes Roku Channel has gained momentum as well. He reiterates an Overweight rating on the shares.
07/17/18
NEED
07/17/18
NO CHANGE
NEED
Hold
Netflix Q2 underscores its 'growing capital intensity', says Needham
Needham analyst Laura Martin kept her Hold rating on Netflix (NFLX), citing the company's missed the Q2 subscriber growth consensus and reduced Q3 guidance. The analyst notes that the quarter has also shown the company's "growing capital intensity" as it "invests in content globally faster than it is driving revenue and sub growth", adding that Netflix enterprise value to paid user ratio has risen to $1,437 from $900 at the start of the year. Martin states that she prefers Roku (ROKU) to Netflix in the OTT industry as its valuation is less than half, its global growth profile is similar, and its expected FY18 free cash flow is better.
07/23/18
NEED
07/23/18
NO CHANGE
Target $60
NEED
Buy
Roku price target raised to $60 from $50 at Needham
Needham analyst Laura Martin raised her price target on Roku (ROKU) to $60 and kept her Buy rating, citing the upside earnings potential from the company's "strong U.S. viewing trends" toward the Over-The-Top viewing generally and "connected TVs specifically". The analyst also notes the rapid adoption of connected TVs for streaming view viewing in and out of home, adding that the company's Rock Channel addresses its total addressable market and potentially doubles the ad revenue per hour streamed. Martin further states that valuation for Roku is "inexpensive" relative to Netflix (NFLX) and expects the company to be "sold before it triples again".

TODAY'S FREE FLY STORIES

SCS

Steelcase

$17.49

-0.115 (-0.65%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Earnings
Steelcase reports Q4 EPS 29c, consensus 26c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 14

    May

  • 24

    Jun

  • 26

    Jun

MYL

Mylan

$28.61

0.44 (1.56%)

16:44
03/19/19
03/19
16:44
03/19/19
16:44
Initiation
Mylan initiated  »

Mylan initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALTR

Altair

$37.68

-0.51 (-1.34%)

16:43
03/19/19
03/19
16:43
03/19/19
16:43
Initiation
Altair initiated  »

Altair initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.19

0.49 (2.16%)

16:42
03/19/19
03/19
16:42
03/19/19
16:42
Initiation
Mallinckrodt initiated  »

Mallinckrodt initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

LCI

Lannett

$8.05

0.17 (2.16%)

16:41
03/19/19
03/19
16:41
03/19/19
16:41
Initiation
Lannett initiated  »

Lannett initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
03/19/19
03/19
16:40
03/19/19
16:40
General news
API crude inventories for week of March 15 »

API reports that crude…

JAZZ

Jazz Pharmaceuticals

$135.47

1.02 (0.76%)

16:40
03/19/19
03/19
16:40
03/19/19
16:40
Initiation
Jazz Pharmaceuticals initiated  »

Jazz Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro suspends 2019 revenue guidance »

Nevro is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

NVRO

Nevro

$44.76

0.37 (0.83%)

16:39
03/19/19
03/19
16:39
03/19/19
16:39
Hot Stocks
Nevro CEO Rami Elghandour steps down, D. Keith Grossman to succeed »

Nevro announced that D.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

ENDP

Endo

$8.78

0.19 (2.21%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Endo initiated  »

Endo initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

METC

Ramaco Resources

$5.67

0.09 (1.61%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Hot Stocks
Ramaco Resources sees FY19 production of 2.0M tons of met coal »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

COST

Costco

$237.05

0.43 (0.18%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Costco initiated  »

Costco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 16

    Apr

  • 30

    May

TRN

Trinity Industries

$22.46

-0.25 (-1.10%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Conference/Events
Trinity Industries management to meet with Stephens »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

COLL

Collegium Pharmaceutical

$17.35

-0.25 (-1.42%)

16:38
03/19/19
03/19
16:38
03/19/19
16:38
Initiation
Collegium Pharmaceutical initiated  »

Collegium Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULT

Fulton Financial

$16.07

-0.35 (-2.13%)

16:37
03/19/19
03/19
16:37
03/19/19
16:37
Hot Stocks
Fulton Financial raises quarterly dividend 1c to 13c per share »

Fulton Financial said its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

METC

Ramaco Resources

$5.67

0.09 (1.61%)

16:36
03/19/19
03/19
16:36
03/19/19
16:36
Earnings
Ramaco Resources reports Q4 EPS 8c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

BDSI

BioDelivery Sciences

$4.94

0.03 (0.61%)

16:35
03/19/19
03/19
16:35
03/19/19
16:35
Initiation
BioDelivery Sciences initiated  »

BioDelivery Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

AMAG

Amag Pharmaceuticals

$12.46

0.01 (0.08%)

16:34
03/19/19
03/19
16:34
03/19/19
16:34
Initiation
Amag Pharmaceuticals initiated  »

Amag Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

  • 23

    Mar

GCP

GCP Applied Technologies

$29.95

-0.475 (-1.56%)

16:34
03/19/19
03/19
16:34
03/19/19
16:34
Hot Stocks
GCP Applied Technologies names James Thompson VP, General Counsel and Secretary »

GCP Applied Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

KGJI

Kingold Jewelry

$0.89

0.0898 (11.22%)

16:33
03/19/19
03/19
16:33
03/19/19
16:33
Hot Stocks
Kingold Jewelry to file extension for Form 10-K »

Kingold Jewelry announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHC

Bausch Health

$26.29

1.745 (7.11%)

16:33
03/19/19
03/19
16:33
03/19/19
16:33
Initiation
Bausch Health initiated  »

Bausch Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TME

Tencent Music

$18.65

-0.48 (-2.51%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Earnings
Tencent Music reports Q4 EPS 8c, consensus 8c »

Reports Q4 revenue $785M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

AMRX

Amneal Pharmaceuticals

$14.41

0.07 (0.49%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Initiation
Amneal Pharmaceuticals initiated  »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

TTGT

TechTarget

$16.86

-0.07 (-0.41%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Hot Stocks
TechTarget CEO Cotoia sells over $134K in company shares »

TechTarget CEO Michael…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 28

    May

FULT

Fulton Financial

$16.07

-0.35 (-2.13%)

16:32
03/19/19
03/19
16:32
03/19/19
16:32
Hot Stocks
Fulton Financial authorizes up to $100M share repurchase »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.